Colobomatous macrophthalmia-microcornea syndrome is a very rare eye condition that is present from birth and runs in families. In this condition, the clear front window of the eye (the cornea) is unusually small (microcornea), but the eyeball itself is longer than normal (macrophthalmia), which causes strong short-sightedness (severe myopia). There are “gaps” or missing pieces of tissue called colobomas in the iris (the colored part) and in the optic disc, where the optic nerve leaves the eye. These structural problems can seriously affect vision in one or both eyes.
Colobomatous macrophthalmia-microcornea syndrome (MACOM) is an extremely rare, inherited eye malformation in which the clear front window of the eye (cornea) is smaller than normal (microcornea), while the eyeball is abnormally long and often enlarged (macrophthalmia), with key-hole–shaped defects called colobomas in the iris, retina and optic nerve. This combination usually causes severe short-sightedness, reduced vision, risk of retinal detachment and high eye pressure (ocular hypertension or glaucoma). [GARD summary][Orphanet review]
This syndrome is autosomal dominant, which means one changed copy of the responsible gene from either parent can be enough to cause the condition. It is so rare that only a few affected families have been reported worldwide, so most of our knowledge comes from small case series rather than large clinical trials. Because of this, there is no “curative” medicine; treatment focuses on protecting vision, treating complications (glaucoma, retinal detachment, cataract, amblyopia), and supporting the person’s quality of life over time.[Genetic overview]
Doctors now know that this syndrome is a genetic, autosomal dominant condition. “Autosomal dominant” means that a person can get the condition if they inherit one changed copy of the gene from either mother or father. The problem is linked to a small missing piece of DNA on chromosome 2, in a region called 2p22.2, which affects genes important for normal eye development.
In families that carry this change, many people may have the condition, but the eye findings can look different from person to person. Some people have very large colobomas and very poor vision; others may have milder changes and see better. So the condition shows “variable expressivity,” which means the same genetic change can cause different levels of severity in different family members.
Other names
Doctors and researchers have used several different names for this same syndrome. All of the names describe the same main idea: a large eye with strong short-sightedness, a small cornea, and colobomas.
Common other names include:
-
Colobomatous macrophthalmia-microcornea syndrome (full descriptive name)
-
Macrophthalmia, colobomatous, with microcornea (often shortened to MACOM)
-
MACOM syndrome
-
Colobomatous macrophthalmia with microcornea syndrome
These names may look different, but they are all talking about the same rare eye disease.
Types
There is no official “type 1, type 2, type 3” classification, but doctors see several patterns. These patterns are helpful to describe what the eyes look like and how severe the disease is in each person.
-
Unilateral type (one-eye involvement) – In some people, only one eye has microcornea, coloboma, and high myopia. The other eye may be normal or only mildly affected. This can cause big vision differences between the two eyes.
-
Bilateral type (both-eyes involvement) – In many reported families, both eyes have the typical signs: small corneas, long eyeballs, colobomas, and strong myopia. The severity may still differ between the two eyes, but both are clearly affected.
-
Anterior-predominant type – In this pattern, problems in the front of the eye are most obvious. The corneas are small and flat, there may be mild cornea plana (a very flat cornea), shallow front chamber, and iris coloboma, while back-of-eye changes are less dramatic.
-
Posterior-predominant type – In some people, the most striking changes are in the back of the eye: large optic disc colobomas, posterior staphylomas (outpouching of the back wall), and severe myopia. The cornea is still small, but the back-of-eye damage mainly determines vision.
-
Type with raised eye pressure (glaucomatous form) – Here, there are angle abnormalities at the drainage area of the eye, shallow front chambers, and raised eye pressure (glaucoma). This form can damage the optic nerve even more and speed up vision loss if the pressure is not controlled.
-
Type without raised eye pressure – Some people have the typical structural defects but normal intra-ocular pressure. Their vision problems mainly come from colobomas and strong myopia, not from glaucoma damage.
Causes
-
CRIM1 gene deletion
The main known cause is a missing part (deletion) of a gene called CRIM1 on chromosome 2. This gene helps control growth signals during eye development, especially around the time the lens and back of the eye are forming. When one copy of CRIM1 is missing, the signals are unbalanced, and the eye tissues do not close and shape correctly, leading to microcornea, long eyeballs, and colobomas. -
FEZ2 gene loss in the same region
The deletion area at 2p22.2 usually includes another gene called FEZ2. FEZ2 is involved in nerve and cell movement. Losing this gene together with CRIM1 creates a “contiguous gene deletion syndrome,” meaning several genes are missing in a row. This combined loss further disrupts the developing eye and adds to the severity of the malformation. -
Autosomal dominant inheritance pattern
In most reported families, one affected parent passes the altered chromosome 2 region to their children. Because the condition is autosomal dominant, every child of an affected parent has a 50% chance of inheriting the deletion and developing the syndrome. Family studies show multiple affected people in several generations with similar eye problems. -
De novo (new) mutations
Sometimes the deletion in CRIM1 and nearby genes does not come from a parent but happens “de novo,” or new, in the egg or sperm or very early embryo. In these cases, the child is the first person in the family with the syndrome, even though later their children can inherit it in an autosomal dominant way. -
Failure of optic fissure closure in early embryo
All colobomas, including those in this syndrome, happen because a gap called the embryonic optic fissure does not close completely during early pregnancy. When this gap stays open, tissue in the iris, retina, choroid, or optic nerve is missing. In MACOM syndrome, the genetic deletion makes this normal closure process fail more often or in a more severe way. -
Abnormal growth of the eyeball length
The genetic problem affects control of eyeball growth, so the eye grows longer than normal from front to back. A long eyeball causes severe myopia and stretches the outer coats of the eye, which contributes to coloboma edges and posterior staphylomas. This abnormal axial growth is a key part of the disease mechanism. -
Disturbed development of the cornea (microcornea)
The same genetic deletion that affects the back of the eye also interferes with corneal development. The cornea ends up with a smaller diameter and can be flatter than normal. A small cornea changes how light enters the eye and is one reason for the refractive error and for crowding in the front of the eye. -
Abnormal formation of the front chamber and angle
Because the cornea is small and the front of the eye is crowded, the anterior chamber (the fluid-filled space in front of the iris) can be shallow, and the drainage angle can be malformed. This structural problem is not a separate disease; it is another result of the same developmental error and leads to raised eye pressure in some patients. -
CRIM1 haploinsufficiency (only one working copy)
“Haploinsufficiency” means that having only one working copy of a gene is not enough for normal function. Studies in humans and animal models show that losing one copy of CRIM1 reduces normal signaling in lens and retinal development, making the tissues more likely to form colobomas and abnormal eye size. -
Disrupted BMP and growth-factor signaling
CRIM1 helps regulate certain growth-factor pathways, including BMP (bone morphogenetic protein) signals, which are important for shaping many organs, including the eye. When CRIM1 is missing, these signals are not controlled properly, which can disturb the patterning of the globe and the closure of the optic fissure. -
Contiguous gene deletion involving multiple nearby genes
In some families, a larger stretch of DNA on 2p22.3–p22.2 is deleted, removing several genes at once. Even if CRIM1 is the main eye-development gene, missing extra neighboring genes may make the eye malformations more severe or slightly change the pattern of findings. -
Genetic background and modifier genes
People in the same family can have different severity of the syndrome, even though they share the main deletion. This suggests that other genes in their background, called modifier genes, may make the eye structures more or less sensitive to the main genetic problem. These modifiers do not cause the disease by themselves but can shape its expression. -
Possible interaction with general coloboma genes
Research on eye colobomas in general has found many genes that guide closure of the optic fissure and patterning of the retina. Although MACOM syndrome is mainly linked to the 2p22.2 deletion, it is likely that shared pathways with other coloboma genes make this failure of closure more likely. -
Embryonic timing sensitivity
Eye development happens during a very specific time window in early pregnancy. If the CRIM1-FEZ2 region is missing, even small changes in timing of cell growth, movement, or death can produce colobomas and abnormal eye size. The early timing of the insult explains why the condition is present from birth. -
High penetrance of the deletion
Most people who carry the 2p22.2 deletion will show some eye changes. This “high penetrance” means that the deletion itself is a strong cause: it is rare to carry the change and have completely normal eyes. However, the exact signs can range from mild to severe, again showing variable expressivity. -
General genetic mutation mechanisms
Like many genetic conditions, the original deletion can be created by normal DNA copying errors, unequal crossing over, or other structural rearrangements in the chromosomes. Once the deletion exists in a family, it can be passed from parent to child according to autosomal dominant rules. -
Non-genetic factors as minor contributors
For MACOM syndrome itself, genes are the main cause. However, as with many genetic diseases, environmental factors such as maternal illnesses, infections, or toxins might slightly modify severity, even if they do not create the basic deletion. These influences are considered possible but not proven main causes. -
Overlap with general microcornea and high-myopia pathways
Microcornea and high myopia also occur in other genetic eye conditions. Shared developmental pathways for corneal size and eyeball length can be disturbed by the MACOM deletion as well, which adds to the extreme severity of short-sightedness in these patients. -
Lack of systemic disease genes in the deleted region
The fact that most patients do not have major problems outside the eye suggests that the deleted genes mainly act in eye development. This focused effect supports the idea that the deletion of CRIM1 and nearby eye-related genes is the primary cause of the syndrome, rather than a broad multi-organ disorder. -
Rarity and founder effects in some families
The syndrome is extremely rare worldwide, and several reports describe many affected people within a single large family. This pattern suggests a “founder effect,” where one original mutation event in an ancestor is passed down many generations, causing the disease in many related individuals.
Symptoms and signs
-
Microcornea (small cornea)
The cornea is the clear dome at the front of the eye. In this syndrome, the corneal diameter is smaller than normal from birth. This can make the eye look slightly different and affects how light bends as it enters the eye. A small cornea is one of the main clues that doctors look for in this condition. -
Severe myopia (very strong short-sightedness)
Because the eyeball is longer than normal, light focuses in front of the retina instead of directly on it. This causes severe myopia, meaning the person can see near objects better than far objects but often needs very strong glasses or contact lenses. In many reported cases, the degree of myopia is extreme. -
Iris coloboma (gap in the colored part of the eye)
Many patients have an iris coloboma, which looks like a keyhole-shaped gap or notch in the colored ring of the eye. This gap is due to missing tissue where the optic fissure did not close. It may cause irregular pupil shape, light sensitivity, or cosmetic concerns. -
Optic disc coloboma
In addition to the iris, the exit point of the optic nerve (the optic disc) often has a coloboma. This means part of the disc and surrounding retina did not form correctly. The defect can interfere with signal transmission from the eye to the brain and is a major cause of reduced vision in this syndrome. -
Posterior staphyloma (outpouching at the back of the eye)
The wall of the eye at the back can stretch out and bulge, forming a posterior staphyloma. This is especially seen in eyes with very high myopia. The staphyloma can distort the retina and increase the risk of additional complications like retinal thinning or detachment. -
Shallow anterior chamber
The anterior chamber is the space between the cornea and the iris. In MACOM syndrome, this space can be shallow because the cornea is small and the front of the eye is crowded. A shallow anterior chamber increases the chance of angle closure and raised eye pressure. -
Angle abnormalities and glaucoma
The angle where the eye fluid drains (between cornea and iris) may be malformed. This makes it harder for the fluid to leave the eye, causing increased intra-ocular pressure and glaucoma in some patients. If untreated, glaucoma can further damage the optic nerve and worsen vision. -
Reduced visual acuity (blurry vision)
Most people with this syndrome have reduced clarity of vision, even with glasses. The combination of severe myopia, colobomas, and staphyloma means the retinal image is not sharp. Visual acuity may range from moderately reduced to very poor, depending on how much of the macula and optic nerve is involved. -
Visual field defects (missing areas in side vision)
Because colobomas often involve the optic disc and surrounding retina, some areas of the visual field may be missing or blurred. Patients may have blind spots, particularly in regions matching the location of the coloboma, even if they do not notice them at first. -
Strabismus (eye misalignment)
When one eye sees much worse than the other, or when the eye structure is very abnormal, the eyes may not line up correctly. This misalignment is called strabismus. It can cause double vision in some children or lead the brain to “ignore” one eye to avoid confusion. -
Nystagmus (involuntary eye movements)
If vision is very poor from early life, the eyes may move quickly back and forth without control. This is called nystagmus. It is not dangerous by itself but shows that the visual system is not getting clear signals, and it can further reduce steady fixation. -
Photophobia (light sensitivity)
The iris coloboma and other structural defects allow extra light to enter the eye in an uncontrolled way. This can make bright light uncomfortable and cause squinting, tearing, or headaches in strong sunlight or glare. Sunglasses or tinted lenses may help but do not fix the underlying issue. -
Risk of retinal detachment
In eyes with high myopia, colobomas, and posterior staphylomas, the retina is stretched and thin in some areas. This increases the risk that the retina may tear and detach. Retinal detachment is a serious complication that can lead to sudden vision loss if not treated quickly. -
Anisometropia (unequal refractive error between the two eyes)
When one eye is more severely affected than the other, the refractive power can be very different between the two eyes. This unequal focus is called anisometropia. It can make it hard for the brain to combine the images from both eyes, and sometimes the weaker eye is suppressed, leading to amblyopia (“lazy eye”). -
Cosmetic differences of the eyes
Because of the small corneas, iris gaps, and sometimes enlarged globe, the eyes may look noticeably different from typical eyes. This cosmetic difference does not add medical danger, but it can affect self-esteem, especially in children and teenagers, and may require supportive counseling.
Diagnostic tests
Physical exam tests
-
General medical and family history
The eye doctor and pediatrician ask detailed questions about vision problems in the child, pregnancy history, and any similar eye problems in relatives. Because MACOM syndrome is autosomal dominant, finding several affected family members strongly supports the diagnosis. A careful pedigree helps to see this pattern across generations. -
Basic visual acuity testing
Standard eye charts (or age-appropriate pictures for young children) are used to measure how clearly each eye can see. Very poor distance vision that does not fully improve with glasses is common in this syndrome and alerts doctors to look for structural causes like colobomas. -
External eye inspection
The doctor looks at the eyes from the outside, checking the size and shape of the corneas, eyelids, and overall globe. Microcornea (small corneal diameter) and visible iris coloboma can often be seen with simple light examination and provide early clues to the diagnosis. -
Pupil and light reflex exam
The reaction of the pupils to light is tested. In eyes with large optic disc colobomas or severe structural damage, the light reflex may be weaker or asymmetrical. This test is simple but important to judge how well the optic nerve and retina are working. -
Intra-ocular pressure measurement (screening)
Non-contact (air-puff) or contact tonometry is used to measure eye pressure. Because angle abnormalities and glaucoma can occur in MACOM, repeated pressure checks are needed over time. Consistently high readings suggest that glaucoma is present and needs treatment.
Manual / clinical instrument tests
-
Slit-lamp examination of the front of the eye
A slit-lamp is a special microscope with a bright light. The doctor uses it to examine the cornea, anterior chamber, iris, and lens in detail. In MACOM syndrome, the slit-lamp shows the small cornea, shallow chamber, and iris coloboma, helping confirm the structural diagnosis. -
Gonioscopy (angle examination)
Gonioscopy uses a small mirror lens placed on the eye to look directly at the drainage angle between the iris and the cornea. In this syndrome, the angle can be abnormal or narrow, explaining why intra-ocular pressure may rise. Gonioscopy helps to decide the risk of glaucoma and plan treatment. -
Dilated fundus examination with indirect ophthalmoscopy
After putting drops to enlarge the pupil, the doctor looks at the back of the eye with a bright light and special lenses. This exam shows the optic disc coloboma, retinal changes, and any posterior staphyloma. It is the key clinical test to see the hallmark posterior findings of MACOM syndrome. -
Refraction and retinoscopy
Refraction testing finds the proper glasses power. In young or uncooperative patients, the doctor may use retinoscopy, shining light and observing reflexes to measure refractive error. In MACOM, this test usually reveals very high myopia, which fits with the long eye and helps support the diagnosis.
Lab and pathological / genetic tests
-
Chromosome microarray (array CGH)
Chromosome microarray looks at many regions of the chromosomes to find missing or extra pieces of DNA. In families with MACOM syndrome, this test can detect the deletion at 2p22.2 that includes CRIM1 and FEZ2. Finding this specific deletion provides strong laboratory proof of the diagnosis. -
Targeted testing of the CRIM1 gene region
If the clinical picture clearly suggests MACOM, more focused tests can examine CRIM1 in detail. Methods like MLPA or targeted sequencing can confirm that exons 15–17 and the nearby region are missing or altered. This targeted approach is often used after a suspicious microarray result. -
Whole-exome sequencing in unclear cases
When a child has eye colobomas and microcornea but the exact genetic cause is not known, whole-exome sequencing can search many genes at once. Studies using this method have confirmed that some patients with MACOM features carry CRIM1 deletions or variants, helping to expand understanding of the condition. -
Basic blood tests for differential diagnosis
Although MACOM syndrome itself is not known to cause body-wide illness, blood tests may be done to rule out other syndromic causes of coloboma or microphthalmia. Tests for infections, metabolic diseases, or systemic syndromes help doctors be sure that the eye problem is not part of a broader disease.
Electrodiagnostic tests
-
Full-field electroretinography (ERG)
ERG measures the electrical responses of the retina to flashes or patterns of light. In eyes with optic disc coloboma and other structural changes, ERG helps to see how well the retina is functioning. It can distinguish between retinal and optic-nerve-based visual loss and is often used in the assessment of complex colobomas. -
Visual evoked potentials (VEP)
VEP records electrical signals from the brain’s visual cortex after light stimulation of the eyes. In children with optic nerve colobomas, VEP helps to measure the strength and speed of visual pathways. Abnormal VEP results may confirm that structural defects in the optic nerve are reducing signal transmission. -
Electro-oculogram (EOG) in selected cases
An EOG measures the electrical potential between the front and back of the eye during eye movements and light changes. While not specific for MACOM, it can help evaluate general retinal pigment epithelium function and may be used when doctors want a more complete electrodiagnostic profile in complex coloboma cases.
Imaging tests
-
B-scan ocular ultrasonography
B-scan ultrasound uses sound waves to produce a two-dimensional image of the eye. It can accurately measure axial length, show posterior staphylomas, and visualize the optic nerve area when the media are not clear. In MACOM, B-scan helps confirm long eyeballs and structural outpouchings at the back of the eye. -
Optical coherence tomography (OCT) of the macula and optic disc
OCT is a non-invasive imaging test that uses light to create cross-section pictures of the retina and optic nerve head. In coloboma and related anomalies, OCT shows the edge of the coloboma, thinning of layers, and any associated macular changes. It helps to understand the anatomy and monitor changes over time. -
Anterior segment OCT or ultrasound biomicroscopy
These imaging methods are focused on the front of the eye. They provide detailed images of the cornea, anterior chamber depth, and angle structures. In MACOM, they can show how shallow the chamber is and how narrow or abnormal the drainage angle appears, supporting glaucoma risk assessment. -
CT or MRI of the orbits in complex or unclear cases
Computed tomography (CT) or magnetic resonance imaging (MRI) of the orbits and brain may be done when doctors need a full picture of globe size, optic nerve structure, or to rule out other brain or orbital abnormalities. These scans can confirm the enlarged globe and the presence of deep posterior staphylomas or cysts if suspected.
Non-pharmacological treatments
(These are supportive options. They do not replace specialist eye care. Always follow the plan made by your pediatric or adult ophthalmologist.)
1. Low-vision rehabilitation
Low-vision rehabilitation teaches a child or adult how to use their remaining vision more effectively with magnifiers, high-contrast reading materials, special lamps and large-print or electronic displays.[Low-vision rehab resources] It also covers skills like reading, writing and using mobile devices with accessibility tools so that school, work and daily living remain possible even with reduced acuity.
2. Optical correction for high myopia
High myopia from the long eyeball is corrected as well as possible with glasses or contact lenses. Proper refraction can improve clarity, help prevent amblyopia (“lazy eye”) in children and reduce eye strain.[High myopia correction] Even if vision cannot be made perfect because of macular or optic nerve coloboma, optimised lenses are a basic step in management.
3. Amblyopia therapy (patching or penalisation)
If one eye sees better than the other, patching the stronger eye or blurring it with special drops or lenses encourages the brain to use the weaker eye. This must be supervised by a pediatric ophthalmologist to avoid harming vision in the good eye and is most effective in early childhood.[Amblyopia management]
4. Regular specialist monitoring and imaging
Frequent eye examinations with pressure measurement, wide-field retinal imaging and sometimes ultrasound or OCT help detect complications such as glaucoma, retinal thinning or early detachment before they cause sudden sight loss.[Coloboma follow-up] Regular monitoring is one of the most important “treatments” for this syndrome.
5. Educational support and assistive technology
Children with significant visual impairment often need an Individualised Education Plan (IEP), seating in the front of the classroom, large-print textbooks, screen magnification software, or text-to-speech devices.[Educational adaptation] These supports can dramatically improve school performance even when vision cannot be fully corrected.
6. Orientation and mobility training
Low-vision specialists or mobility instructors can teach safe navigation at home, in school and outdoors, sometimes using contrast markings, tactile cues, or a mobility cane if vision is severely reduced.[Orientation and mobility training] This improves independence and reduces the risk of falls and injury.
7. Protective eyewear
Because the eye structure is abnormal and often fragile, impact-resistant glasses or sports goggles help prevent serious trauma during play, sports and routine activities. Protecting the better-seeing eye is especially important when one eye is more affected.[Eye protection advice]
8. Light and contrast optimisation at home and school
Adjusting lighting (avoiding glare but using good task lighting), using high-contrast print (dark letters on white), and increasing font sizes are simple, non-drug steps that can make reading and daily tasks easier.[Visual environment adaptation]
9. Family genetic counselling
Genetic counselling helps families understand inheritance patterns, recurrence risk in future pregnancies and options such as prenatal or pre-implantation diagnosis.[Genetic counselling explanation] It also supports emotional coping with a rare, complex condition.
10. Psychosocial and peer-support counselling
Living with a visible eye difference and reduced vision can cause anxiety, low mood and social difficulties. Psychologists and peer groups for rare eye disease can help children and parents share experiences, reduce isolation and learn coping skills.[Rare disease support groups]
11. Management of dry eye and ocular surface strain
Frequent screen use or reduced blinking due to visual concentration can cause dryness and discomfort. Non-preserved lubricating eye drops, using the 20-20-20 rule (frequent breaks) and humidifying the environment can relieve symptoms under guidance from the eye specialist.[Dry eye management]
12. Posture and ergonomics training
Because many patients adopt unusual head positions to use the best-seeing area of the retina, physiotherapists and occupational therapists can help design seating and desk setups that avoid neck and back strain while still supporting visual function.[Ergonomic adjustment]
13. Early intervention and developmental programmes
Babies and toddlers with visual impairment benefit from early developmental programmes that teach parents how to stimulate vision safely and encourage normal motor and social development.[Early intervention services]
14. Strabismus (squint) therapy with glasses or prisms
When eyes are misaligned (strabismus), carefully prescribed glasses or prism lenses can sometimes improve alignment and reduce double vision, delaying or reducing the need for surgery in selected cases.[Strabismus management]
15. UV-blocking sunglasses and hats
Because of abnormal eye structure and possible light sensitivity, UV-blocking sunglasses and wide-brimmed hats help reduce photophobia and protect ocular tissues from ultraviolet damage over the long term.[UV protection advice]
16. Home safety adaptations
Good lighting on stairs, contrasting edges, clutter-free floors and labelled storage areas lower the risk of falls and accidents for people with reduced peripheral or central vision.[Home safety for low vision]
17. Vision-friendly hobbies and activities
Choosing hobbies that use tactile or auditory skills (music, crafts with bold materials, audio books, adapted sports) supports mental health and prevents frustration from visually demanding activities that are too hard.[Adaptive leisure activities]
18. Tele-ophthalmology and remote follow-up
In regions with limited specialists, secure video consultations and remote sharing of retinal images can help maintain follow-up and adjust treatment plans without frequent long-distance travel.[Telemedicine in eye care]
19. Multidisciplinary clinic visits
Seeing cornea, retina, glaucoma, pediatric and low-vision specialists in a multidisciplinary centre reduces fragmented care and ensures that all aspects of the syndrome are monitored together.[Multidisciplinary rare-disease care]
20. Parental and caregiver education programmes
Teaching caregivers to recognise danger signs (eye pain, sudden vision changes, new floaters, eye enlargement) and to use drops and patches correctly is essential for successful long-term management.[Caregiver education]
Drug treatments
Important: There is no medicine that “cures” colobomatous macrophthalmia-microcornea syndrome. The drugs below are used to treat complications such as glaucoma, inflammation, infection or macular swelling. Doses and combinations must always be chosen by a pediatric or adult ophthalmologist. Never start, stop or change eye medicines on your own.
Because this syndrome is so rare, there are no trials of 20 specific named drugs just for this condition. Instead, specialists use standard, evidence-based medicines approved by the U.S. Food and Drug Administration (FDA) or other agencies for glaucoma, inflammation and retinal disease, and sometimes use them “off-label” when needed.[FDA drug labels]
Below are examples of commonly used drug classes and key molecules (not a complete list):
1. Prostaglandin analog eye drops (e.g., latanoprost)
Latanoprost lowers eye pressure by increasing fluid outflow from the eye. It is FDA-approved for open-angle glaucoma and ocular hypertension; the official label recommends one drop in the affected eye(s) once daily in the evening, not more than once per day.[Latanoprost label] In MACOM, a pediatric glaucoma specialist may consider similar drugs when there is high intraocular pressure, balancing benefits with risks like eye redness and eyelash changes.
2. Topical beta-blocker eye drops (e.g., timolol)
Timolol eye drops reduce aqueous fluid production and help lower intraocular pressure. The FDA label describes it as a non-selective beta-adrenergic blocker indicated for ocular hypertension and open-angle glaucoma.[Timolol label] In children or syndromic eyes, it is used cautiously because it can affect heart rate and breathing, especially in asthma or cardiac disease.
3. Carbonic anhydrase inhibitor eye drops (e.g., dorzolamide)
These drops reduce fluid formation inside the eye and are often combined with beta-blockers to control pressure when one medicine is not enough. Side effects include stinging and, rarely, corneal changes. They are frequently used in pediatric glaucoma associated with anterior segment malformations.[Pediatric glaucoma therapies]
4. Alpha-2 adrenergic agonist drops (e.g., brimonidine in older children/adults)
Brimonidine decreases aqueous production and increases uveoscleral outflow. It can cause fatigue and drowsiness and is generally avoided in very young children because of the risk of systemic side effects.[Brimonidine safety information] It may be considered in older patients when other drops are inadequate.
5. Fixed-combination glaucoma drops
Combinations such as prostaglandin + beta-blocker or beta-blocker + carbonic anhydrase inhibitor allow multiple mechanisms in a single bottle, which may improve adherence in complex regimens. These are chosen by the glaucoma specialist according to pressure targets and tolerance.[Combination glaucoma therapy]
6. Systemic carbonic anhydrase inhibitors (e.g., acetazolamide)
Short courses of oral acetazolamide may be used when eye pressure is dangerously high or while waiting for surgery. They work by reducing aqueous production but can cause tingling sensations, kidney stones, electrolyte imbalance and stomach upset, so they are monitored carefully.[Acetazolamide use in glaucoma]
7. Topical corticosteroid drops (e.g., prednisolone acetate)
After eye surgery or during inflammatory episodes, corticosteroid drops calm inflammation in the front of the eye. Labels such as PRED FORTE or OMNIPRED describe use for steroid-responsive anterior segment inflammation but warn that steroids can raise eye pressure and worsen infection risk, so monitoring is essential.[Prednisolone eye drop labels]
8. Combination steroid–antibiotic drops or ointments
When there is both inflammation and risk of surface infection (for example after surgery), combined preparations (steroid plus antibiotic) may be used for a short period under close supervision.[Steroid-antibiotic combinations] These reduce pain and redness but must be tapered carefully.
9. Cycloplegic and mydriatic drops (e.g., atropine, cyclopentolate)
These drops temporarily relax the focusing muscle and dilate the pupil. They are used for accurate refraction, amblyopia treatment and some forms of pain or inflammation. Overuse can cause blurred near vision, light sensitivity, and systemic effects in small children, so dosing is strictly controlled.[Cycloplegic use in pediatrics]
10. Intravitreal anti-VEGF injections (e.g., ranibizumab)
In rare cases, abnormal blood vessels or macular complications may develop in colobomatous eyes. Anti-VEGF drugs like ranibizumab (LUCENTIS, BYOOVIZ) are FDA-approved for macular diseases and are delivered as injections into the eye at intervals described on the label (commonly monthly at first).[Ranibizumab labels] Use in structural anomalies is highly specialised and done only by vitreoretinal surgeons.
11. Topical non-steroidal anti-inflammatory drops (e.g., ketorolac)
These drops may be used short-term around cataract or retinal surgery to reduce inflammation and macular swelling. They can sting and may very rarely affect corneal healing, so the surgeon decides the course and duration.[NSAID eye drop use]
12. Lubricating / artificial tear drops and gels
Although usually classified as medical devices or over-the-counter products, preservative-free lubricants are important to relieve dryness from large eyes, scarring or frequent surgery. They improve comfort and may protect the ocular surface but do not change the underlying malformation.[Artificial tears guidance]
(Further medicines—like systemic pain relief, antibiotics, or drugs for associated systemic conditions—are chosen individually. Because evidence is limited, it is safer not to “force” a list of named drugs with detailed dosing for this very rare syndrome.)
Dietary molecular supplements
Supplements cannot repair a coloboma or microcornea. They may support overall eye and body health but should only be used under medical guidance, especially in children.
1. Omega-3 fatty acids (EPA/DHA)
Omega-3 fats from fish oil or algae have anti-inflammatory effects and may help tear film quality and general retinal health, based on studies in dry eye and age-related macular degeneration.[Omega-3 and eye health] They are usually taken with food to reduce stomach upset. High doses can increase bleeding risk, so dose and need must be checked with a doctor.
2. Lutein and zeaxanthin
These carotenoids accumulate in the macula and act as natural blue-light filters and antioxidants. Trials in macular degeneration suggest they can modestly improve macular pigment and function.[Macular carotenoids] In MACOM, they are sometimes used as general support for retinal health, but there is no direct evidence that they change the course of the syndrome.
3. Vitamin A (within safe limits)
Vitamin A is essential for photoreceptor function. Severe deficiency causes night blindness and other eye problems. However, excess vitamin A is toxic, especially in young children and pregnancy.[Vitamin A and vision] Any vitamin A supplement should stay within recommended daily allowances unless a deficiency is confirmed by a physician.
4. Vitamins C and E (antioxidants)
These antioxidants help neutralise free radicals and have been studied in age-related eye disease. The AREDS trials in older adults suggested benefit in slowing some forms of macular degeneration with specific high-dose antioxidant and zinc combinations.[AREDS findings] In MACOM, more modest doses in a standard multivitamin may support general health but are not a specific therapy.
5. Zinc
Zinc plays roles in retinal enzyme systems and was part of the AREDS formula. High doses can cause stomach upset and interfere with copper absorption.[Zinc in ocular health] If used, a balanced antioxidant formula supervised by a doctor is safer than isolated very high-dose zinc.
6. B-complex vitamins (including B12 and folate)
B-vitamins support nerve health and general metabolism. Deficiency can contribute to fatigue and neurological problems. While there is no direct evidence that they improve MACOM, ensuring adequate intake through food or supervised supplements supports overall health and learning ability.[B-vitamins and nervous system]
7. Vitamin D
Vitamin D is important for bone health, immunity and possibly ocular surface balance. Many children and adults, especially those with limited outdoor activity, can be deficient.[Vitamin D deficiency] Correcting deficiency may improve general wellbeing, but dosing must be based on blood tests ordered by the doctor to avoid overdose.
8. Coenzyme Q10
CoQ10 is involved in mitochondrial energy production and is being researched in neuro-protection, including some glaucoma studies.[CoQ10 and glaucoma] Its role in MACOM is unproven but may be discussed as an adjunct in adults, considering cost and limited evidence.
9. Probiotics (gut microbiome support)
Healthy gut bacteria may influence systemic inflammation. While evidence for direct eye benefits is still emerging, a diet rich in fibre and possibly medically-supervised probiotics can support general health, which indirectly helps coping with a chronic condition.[Microbiome and immunity]
10. Mixed “eye-health” multivitamins
Commercial eye-health supplements usually combine carotenoids, antioxidants and zinc. They are based mainly on adult macular degeneration data and not on congenital coloboma.[Eye-health multivitamins] If considered, the ophthalmologist should review ingredients and doses, especially in children, to avoid overdose.
Immunity-booster, regenerative and stem-cell–related drugs
At present, there are no approved regenerative or stem-cell drugs specifically for colobomatous macrophthalmia-microcornea syndrome. Most regenerative therapies are still in clinical trials for other retinal diseases. Any use must occur inside carefully controlled research studies.
Examples of research areas (not home treatments):
-
Gene therapy for inherited retinal diseases – Licensed products such as voretigene neparvovec target specific gene defects (e.g., RPE65) and show that replacing genes can improve function in some conditions, but these are not designed for MACOM.[Gene therapy overview]
-
Stem-cell–derived retinal pigment epithelium (RPE) transplants – Experimental trials transplant lab-grown RPE cells to support damaged macula in diseases like macular degeneration, with mixed early results and significant surgical risk.[Stem-cell eye trials]
-
Neuroprotective agents in glaucoma – Some drugs and supplements are being studied to protect retinal ganglion cells from damage in glaucoma, beyond simply lowering pressure.[Neuroprotection in glaucoma]
-
Immunomodulatory biologic drugs for uveitis – In patients with associated inflammatory eye disease, systemic biologics can protect ocular structures, but this is a separate diagnosis and requires a rheumatology–ophthalmology team.[Biologics in ocular inflammation]
-
Experimental scleral reinforcement materials – In highly myopic eyes with staphyloma, researchers are exploring materials to support the back of the eye and slow stretching.[Myopia control surgery research]
-
Clinical-trial vaccines or immune-modulating strategies – These are aimed at broader immune disorders or infections and not specifically at MACOM, but good vaccination and infection prevention are still vital for overall eye and brain health.[Rare-disease care strategies]
For a teenager or child, the key message is: if you hear about “stem-cell cures” online, talk to your ophthalmologist and avoid unregulated clinics, because many are unsafe and not evidence-based.
Surgical treatments
1. Prophylactic laser photocoagulation around chorioretinal coloboma
Retinal specialists sometimes apply laser burns at the border of a chorioretinal coloboma to “weld” the retina more firmly and reduce the risk of future detachment. Evidence suggests this can lower risk in selected cases, but the anatomy is complex and not all eyes are suitable.[Coloboma prophylactic laser]
2. Pars plana vitrectomy with endolaser and tamponade for retinal detachment
If a retinal detachment occurs, surgery often involves vitrectomy (removing the vitreous gel), sealing tears with laser and filling the eye with gas or silicone oil as a temporary internal “splint”. Outcomes are variable because the coloboma area is fragile, but modern techniques have improved success.[Retinal detachment management]
3. Glaucoma surgeries (goniotomy, trabeculotomy, trabeculectomy, drainage devices)
When drops and medicines cannot control eye pressure, surgeons may open the drainage angle (goniotomy/trabeculotomy), create a new outflow path (trabeculectomy) or insert drainage devices. Pediatric anterior segment anomalies make these procedures more challenging, so they are performed by glaucoma specialists.[Pediatric glaucoma surgery]
4. Cataract surgery with or without intraocular lens implantation
Cataracts can develop earlier in malformed eyes. Cataract removal can improve vision but is technically demanding because of small corneas, shallow chambers and colobomatous retina. Surgeons must carefully decide whether to implant an intraocular lens or fit contact lenses instead.[Cataract in coloboma]
5. Corneal or scleral procedures for severe microcornea or staphyloma
In selected cases with very small corneas, scarring or severe posterior staphyloma, corneal grafting or scleral reinforcement procedures may be considered. These are high-risk, rare operations reserved for eyes where potential benefit clearly outweighs substantial surgical risk.[Complex ocular reconstruction]
Prevention and protection strategies
Because MACOM is genetic, we cannot prevent the original malformation, but we can reduce complications and protect remaining vision:
-
Early diagnosis and referral – Any baby or child with unusual-looking eyes, nystagmus or poor visual tracking should see an ophthalmologist early.[Early detection benefits]
-
Regular lifelong follow-up – Stick to the follow-up schedule to catch glaucoma, detachment or cataract early.
-
Consistent use of prescribed glasses, patches and drops – Correct use improves visual development and reduces risk of permanent amblyopia or pressure damage.
-
Eye protection in sports and play – Use sports goggles and avoid high-impact activities without protection.
-
Prompt treatment of eye infections or trauma – Redness, pain or injury should be evaluated quickly to avoid scarring or detachment.
-
Healthy pregnancy and newborn care – For future pregnancies, good antenatal care and avoiding harmful exposures support overall fetal development, although they cannot fully prevent a genetic syndrome.[Genetic counselling and pregnancy]
-
Good general health (sleep, nutrition, exercise) – Supports learning, recovery from surgery and resilience in living with a chronic rare disease.
-
Genetic counselling for family planning – Helps families understand recurrence risk and options.
-
Avoiding smoking and heavy alcohol exposure in the home – Protects eye and systemic health, especially in children.
-
Building a strong care team – A trusted ophthalmologist, pediatrician, teacher and counsellor working together reduces delays and mistakes in care.[Care team advice]
When to see doctors urgently
You should contact an eye doctor immediately or go to emergency care if you or your child with this syndrome has:
-
Sudden worsening of vision, a “curtain” or shadow over part of the visual field (possible retinal detachment)[Retinal detachment symptoms]
-
New flashes of light or many floaters
-
Severe eye pain, redness, nausea or vomiting (possible acute glaucoma or inflammation)[Acute glaucoma warning]
-
Rapid enlargement of the eye or bulging
-
Recent eye trauma, even if it seems minor
-
After surgery: increasing pain, discharge, or sudden visual loss
Routine follow-up with the ophthalmologist is also needed even when there are no symptoms, because some changes (like slowly rising eye pressure) are silent at first.
What to eat and what to avoid
(Diet cannot fix the eye malformation but supports general and eye health.)
1. Eat plenty of leafy green vegetables
Spinach, kale and similar vegetables provide lutein, zeaxanthin and vitamins important for retinal and overall health.[Leafy greens and eye health]
2. Include colourful fruits and vegetables
Orange, red and yellow produce (carrots, sweet potatoes, peppers, mangoes) supply carotenoids and vitamin C, supporting general eye and immune health.
3. Choose oily fish 1–2 times per week (if allowed)
Fish like salmon, sardines or mackerel provide omega-3 fats linked to better tear film and retinal support.[Omega-3 foods]
4. Prefer whole grains and high-fibre foods
Whole grains, pulses and beans stabilise blood sugar and support gut health, which contributes to overall wellbeing.
5. Stay well hydrated
Adequate water intake helps comfort of the ocular surface and general body function. Sugary drinks should be limited.
6. Limit ultra-processed, high-sugar and high-salt foods
Frequent fast food, sugary snacks and drinks contribute to obesity and metabolic disease, which can complicate many eye problems in later life.
7. Avoid smoking and second-hand smoke
Smoke exposure damages blood vessels and is harmful to both general health and ocular tissues.
8. Avoid excessive alcohol in older patients
Heavy alcohol is harmful to the nervous system and overall health and should be avoided; adolescents should not drink at all.
9. Be cautious with “mega-dose” supplements
Very high doses of single vitamins or minerals can be toxic, especially vitamin A and zinc. Any supplement plan should be checked with a doctor.
10. Tailor diet to other medical conditions
If there are additional diagnoses (e.g., kidney or metabolic problems), diet must match those needs; a pediatrician or dietitian can help design a safe plan.
Frequently asked questions (FAQs)
1. Can colobomatous macrophthalmia-microcornea syndrome be cured?
No. Current treatments cannot repair the basic developmental malformation. Management focuses on maximising remaining vision, treating complications and supporting quality of life.[MACOM overview]
2. Is it always inherited from a parent?
It is usually autosomal dominant, but the first person in a family can have a new mutation. Genetic counselling can clarify inheritance and risks for future children.[Inheritance explanation]
3. Will my child go blind?
Visual outcomes vary widely. Some people have moderate vision, while others have severe impairment, depending on how much the macula and optic nerve are affected and whether complications like retinal detachment or glaucoma can be controlled.[Outcome data]
4. Is there anything we can do at home to improve vision?
You cannot change the anatomy, but you can help by ensuring good adherence with glasses, patches and drops, protecting the eyes from injury, optimising lighting and following low-vision advice from the care team.[Home support strategies]
5. Are eye exercises useful?
Formal vision therapy may help some issues such as convergence or tracking, but it cannot remove a coloboma or microcornea. Any exercise programme should be supervised by the ophthalmologist or orthoptist.[Vision therapy evidence]
6. Can laser or cosmetic surgery fix the iris coloboma “keyhole pupil”?
In selected cases, surgeons can partially close an iris coloboma for better cosmesis or to reduce glare, but this must be balanced against the structural risks in a malformed eye.[Iris surgery in coloboma]
7. Is pregnancy safe for someone with this syndrome?
Most people can have a normal pregnancy, but high myopia and retinal anomalies may require closer eye monitoring. Genetic counselling can discuss recurrence risk for the baby.[Pregnancy and rare eye disease]
8. Will my child need many surgeries?
Some children never need surgery; others require operations for glaucoma, retinal detachment or cataract. Decisions depend on eye pressure, retinal status and visual development.[Surgical burden data]
9. Can my child play sports?
Yes, but with appropriate eye protection and avoiding high-impact sports without goggles. The ophthalmologist can advise which activities are safest in each case.[Sports and eye protection]
10. Are stem-cell clinics offering cures trustworthy?
Most “miracle cure” clinics advertised online are not regulated and have no solid evidence. They can be dangerous and expensive. Only consider treatments within recognised clinical trials at university or specialist centres.[Stem-cell warning]
11. Does screen time damage the eyes more in this syndrome?
Screens do not worsen the anatomical malformation, but long sessions can cause eye strain and dryness. Regular breaks, good lighting and reasonable limits are sensible for everyone.[Screen use and eye strain]
12. Can contact lenses be used instead of glasses?
In some patients, specially fitted contact lenses can provide better optics for high myopia or irregular corneas. Fitting is more complex and requires excellent hygiene and frequent follow-up.[Contact lenses in complex eyes]
13. Is driving possible later in life?
This depends on visual acuity and field in the better eye and on local legal standards. Some adults with milder involvement may meet driving criteria with correction; others will not. The ophthalmologist can advise once the vision is stable.[Driving and vision standards]
14. Are there patient organisations for this syndrome?
Because it is very rare, there may not be syndrome-specific groups, but rare-disease networks and eye-disease organisations listed by GARD and Orphanet can help connect families.[Patient organisation search]
15. What is the single most important thing families can do?
The most important step is to build a long-term relationship with a knowledgeable pediatric or adult ophthalmologist, keep follow-up appointments, and ask questions whenever you are unsure. Combined with good home support, this gives the best chance to protect the vision that is present.[Care-team importance]
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: February 10, 2025.
